نتائج البحث

An Open-Label, Randomized, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 in Pediatric Subjects Aged 10 to Less Than 18 Years for the Treatment of Relapsing-Remitting Multiple Sclerosis, With Optional Open-Label Extension قائمة الدراسات السريرية المسجلة على الادوية

A Phase IIIb, Interventional, Multicentre, Multinational, Randomised, Open-label Trial to Compare the Efficacy and Safety of Ovarian Stimulation With GONAL-f® and Luveris® Starting on Day 1 vs. Day 6 in Women Between 36 and 42 Years of Age Undergoing Assisted Reproductive Technique (ART) قائمة الدراسات السريرية المسجلة على الادوية

Inactivated Avian Infectious Bronchitis virus strain H52/Newcastle Disease virus inactivated La Sota strain/ Egg Drop Syndrome 76 Adenovirus-127 strain قائمة الأدوية تحت التسجيل / قائمة الأدوية المعروضة على لجنة التسجيل

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multinational Clinical Study to Evaluate the Efficacy and Safety of 2.0 mg/kg/Week and 2.0 mg/kg/Every Other Week BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome) قائمة الدراسات السريرية المسجلة على الادوية

"Phase 3, Open/Label Study to evaluate the safety and efficacy of TMC 435 plus Pegylated Interferon alfa-2a and Ripavirin administrated for 12 weeks in treatment-naïve Subjects with Chronic genotype 1 or genotype 4 HCV infection" قائمة الدراسات السريرية المسجلة على الادوية

"A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlledClinical Study to Evaluate the Safety and Efficacy of Ertugliflozin (MK-8835/PF-04971729)in Pediatric Participants (ages 10 to 17 years, inclusive) with Type 2 Diabetes Mellitus" قائمة الدراسات السريرية المسجلة على الادوية

Omega-3 Acid Ethyl ester- EPA-36 percent and DHA-24 percent Equivalent to EPA 180 mg and DHA 120 mg/ Sea Buckthorn Seed Oil/ Astaxanthin 5 percent Oil قائمة الأدوية تحت التسجيل / قائمة الأدوية المعروضة على لجنة التسجيل

A randomized, double blind, placebo controlled, parallel group, pilot study of 1:1 and 20:1 ratio of formulated GWP42003: GWP42004 plus GWP42003 and GWP42004 alone in the treatment of dyslipedemia in subjects with Type 2 diabetes. قائمة الدراسات السريرية المسجلة على الادوية

Outcomes of Extended Depth of Focus IOL versus Monofocal IOL Implantation After Phacoemulsification in Glaucoma Patients قائمة دراسات سريرية

Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients with Advancing Heart Failure قائمة دراسات سريرية

عرض 2051 - 2060 من 2073